Aldo Scarpa Selected Research

trichostatin A (A 300)

4/2009	Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study.
7/2007	Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.
5/2007	Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A.
6/2006	Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation.
11/2005	Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A.
9/2004	Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells.
8/2004	Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis.
10/2003	Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
6/2003	Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aldo Scarpa Research Topics

Disease

178	Neoplasms (Cancer) 07/2022 - 07/2002
59	Adenocarcinoma 11/2022 - 07/2002
52	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 07/2002
35	Neoplasm Metastasis (Metastasis) 06/2022 - 02/2002
19	Carcinoma (Carcinomatosis) 11/2021 - 05/2004
17	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022 - 03/2005
12	Carcinogenesis 01/2021 - 07/2002
10	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2013
9	Cholangiocarcinoma 01/2020 - 12/2013
7	Neuroendocrine Carcinoma 06/2022 - 12/2005
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 12/2005
7	Hypoxia (Hypoxemia) 01/2019 - 08/2003
7	Carcinoid Tumor (Carcinoid) 06/2018 - 03/2005
6	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 04/2007
6	Chronic Pancreatitis 01/2018 - 11/2008
6	Pancreatic Ductal Carcinoma 01/2014 - 06/2003
4	Acinar Cell Carcinoma 06/2022 - 10/2006
4	Microsatellite Instability 06/2022 - 04/2010
4	Adenocarcinoma of Lung 01/2022 - 01/2013
4	Extranodal Extension 08/2021 - 11/2016
4	Lymphoma (Lymphomas) 01/2021 - 12/2013
4	Glioma (Gliomas) 08/2020 - 05/2016
4	Glioblastoma (Glioblastoma Multiforme) 08/2019 - 01/2009
4	Necrosis 01/2019 - 01/2013
4	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 01/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 07/2007
4	Neoplasms, Cystic, Mucinous, and Serous 01/2017 - 01/2014
4	Insulinoma 01/2015 - 07/2002
4	Sickle Cell Anemia (Hemoglobin S Disease) 01/2011 - 08/2003
3	Meningioma (Meningiomas) 06/2022 - 02/2021
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 04/2018
3	B-Cell Lymphoma (Lymphoma, B Cell) 07/2018 - 08/2003
3	Stomach Neoplasms (Stomach Cancer) 12/2016 - 04/2010
3	Breast Neoplasms (Breast Cancer) 02/2015 - 09/2013
3	Lymphatic Metastasis 01/2015 - 03/2005
2	Oligodendroglioma 04/2022 - 02/2020
2	Malignant Mesothelioma 01/2022 - 01/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

51	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2002
41	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2006
19	DNA (Deoxyribonucleic Acid)IBA 08/2019 - 01/2005
17	Pharmaceutical PreparationsIBA 01/2022 - 08/2002
17	Messenger RNA (mRNA)IBA 01/2021 - 07/2002
16	Biological ProductsIBA 06/2022 - 01/2010
16	MicroRNAs (MicroRNA)IBA 11/2021 - 02/2006
9	Gemcitabine FDA Link 01/2020 - 03/2004
9	trichostatin A (A 300)IBA 04/2009 - 06/2003
8	Protein Isoforms (Isoforms)IBA 11/2020 - 08/2003
6	CytokinesIBA 01/2021 - 01/2006
6	ParaffinIBA 08/2019 - 01/2014
6	RNA (Ribonucleic Acid)IBA 08/2019 - 08/2003
6	Interleukin-6 (Interleukin 6)IBA 01/2016 - 08/2003
6	theasinensin AIBA 04/2009 - 06/2003
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2005
5	Phosphotransferases (Kinase)IBA 10/2020 - 04/2007
5	beta CateninIBA 01/2018 - 05/2003
5	Histone Deacetylase InhibitorsIBA 04/2009 - 10/2003
5	Histone Deacetylases (Histone Deacetylase)IBA 07/2007 - 06/2003
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022 - 06/2013
4	Histones (Histone)IBA 03/2022 - 11/2005
4	LigandsIBA 01/2022 - 07/2005
4	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 10/2003
4	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 09/2006
4	AntigensIBA 01/2019 - 08/2007
4	AntibodiesIBA 11/2018 - 03/2014
4	MTOR InhibitorsIBA 06/2018 - 01/2010
4	Capsules (Microcapsules)IBA 06/2018 - 10/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017 - 09/2006
4	Interleukin-10 (Interleukin 10)IBA 06/2008 - 01/2006
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2015
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 11/2015
3	Calcibiotic Root Canal SealerIBA 08/2021 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2021 - 08/2003
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2020 - 01/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2015
3	Small Interfering RNA (siRNA)IBA 01/2020 - 03/2013
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 04/2015
3	Monoclonal AntibodiesIBA 10/2019 - 10/2011
3	Formaldehyde (Formol)FDA Link 10/2018 - 01/2014
3	TOR Serine-Threonine KinasesIBA 06/2018 - 10/2011
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 09/2002
3	EnzymesIBA 12/2017 - 12/2013
3	ChromatinIBA 09/2017 - 03/2016
3	human ERBB2 proteinIBA 02/2015 - 12/2005
3	Peptides (Polypeptides)IBA 11/2010 - 08/2003
2	CateninsIBA 07/2022 - 01/2017
2	Colloids (Colloid)IBA 06/2022 - 01/2022
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 06/2015

Therapy/Procedure

52	Therapeutics 01/2022 - 11/2002
15	Drug Therapy (Chemotherapy) 04/2022 - 06/2006
12	Immunotherapy 06/2022 - 01/2017
8	Precision Medicine 01/2022 - 06/2014
6	Neoadjuvant Therapy 01/2018 - 02/2015
5	Pancreaticoduodenectomy 11/2022 - 05/2007
5	Pancreatectomy 01/2021 - 03/2009
4	Semiconductors 01/2016 - 01/2014
3	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 10/2013
3	Castration 10/2018 - 01/2016
2	Radiotherapy 04/2022 - 12/2020